PMMI ProSource – Start Your Search
Check out our packaging and processing solutions finder, PMMI ProSource.

FDA Declines Approval for Two Chinese Cancer Drugs

This is the latest move in the FDA’s increasingly strict stance on approving drugs developed in Asian countries.

103578105 Getty Images 496532228
Getty Images

According to a recent Reuters article, the FDA declined to approve two cancer treatments developed in China. The drugs in question are Hutchmed’s pancreatic cancer treatment and a throat cancer medicine developed by Junshi and Coherus. Single-country trials are responsible for the rejection of the former, while manufacturing issues held up the latter.